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Abstract
Previous studies have found that common genetic variants on chromosome 8q24 are associated with the risk of developing
colorectal neoplasia. We conducted a hospital-based case-control study, including 435 cases and 788 unrelated controls to
investigate the associations between common variants on 8q24 and the risk of colorectal cancer in a Chinese population.
We also evaluated the association of rs6983267 with colorectal neoplasia in the published literature via a meta-analysis
study. We found that rs6983267 was significantly associated with the risk of colorectal cancer in the Chinese population,
with an adjusted odds-ratio (OR) for the GT heterozygotes and GG homozygotes of 1.30 (95% CI =0.98–1.71, P=0.069) and
1.66 (95% CI =1.18–2.34, P=0.004), respectively, compared to the TT homozygotes, with a P-trend value of 0.003. No
association was found for the other three loci (rs16901979, rs1447295 and rs7837688). In the meta-analysis of the published
genetic association studies, the rs6983267 variant was found to be associated with an increased risk of colorectal neoplasia.
The heterozygous GT carriers showed a 20% increased risk of colorectal neoplasia (OR =1.20, 95% CI =1.16–1.25; random
effects model) with a summary OR for homozygous GG carriers of 1.39 (95% CI =1.32–1.48; random effects model)
compared to the TT genotype carriers. We found no significant differences between the association of rs6983267 and
colorectal cancer and colorectal adenomas. In summary, our study confirms that the variant rs6983267 is a risk factor for
colorectal neoplasia in various populations, including the Chinese population.
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Introduction
Colorectal cancer (CRC) is the third most common cancer and
the fourth most frequent cause of cancer death worldwide [1]. The
lifetime risk in Western European and North American popula-
tions is around 5% [2]. Among the risk factors and causes for
CRC, inherited genetic factors account for approximately 35% of
the disease etiology [2]. Many genetic factors, such as mutations of
critical genes (e.g. APC, MLH1, MSH2, TGFBR2 and SMAD4)
have been identified [3]. However, many factors that increase the
susceptibility to CRC, but with low penetrance need to be
explored. In the past few years, several genome-wide association
studies (GWAS) have identified novel loci that are associated with
CRC risk, such as variants on 11q23 [2], 8q24 [4,5,6], 10p14 [7],
8q23.3 [7], 15q13.3 (HMPS) [8] and SMAD7 [9]. However, the
extent to which these genetic factors contribute to the disease has
not been established.
Among these loci, variants on 8q24 have shown strong evidence
of an association with the risk of CRC in different populations.
Haiman et al genotyped six variants in 1,124 individuals with
invasive CRC and 4,573 controls that had been previously
identified as having an underlying risk for prostate cancer due to
alterations on 8q24 [10] and found that one variant, rs6983267,
was also significantly associated with colorectal cancer [4].
Similarly, Tomlinson et al conducted a genome-wide association
study of 550,000 tag SNPs in 930 familial colorectal cancer
patients and 960 controls and found that rs6983267 had the
strongest association with CRC risk [5]. Analyses based on 1,477
individuals with colorectal adenoma and 2,136 controls suggested
the possibility that this locus is involved in tumor initiation rather
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e18251than progression [5]. SNP rs10505477, which maps about 5.86 kb
centromeric to rs6983267 and has a high linkage disequilibrium
with rs6983267, was also found to be associated with CRC risk,
and has been implicated across many cohort and case-control
studies [5,11,12,13]. It has also been reported that five different
haplotype blocks at the 8q24 region have been identified, and only
those loci located between the 128.47 Mb and the 128.54 Mb
region (e.g. rs6983267, rs10808556 and rs10505477) were
associated with CRC risk. The variations in the other regions
were found to be associated with prostate, breast and ovarian
cancers [14].
The constantly improving standard of living in China has
brought about extensive changes to the lifestyle and diet of the
average Chinese citizen over the past three decades, and has led to
a corresponding increase in the incidence and mortality of CRC in
China [15]. The steady increase in the incidence and mortality of
CRC has made the disease one of the leading causes of death in
China. However, few studies have examined the genetic factors
that influence the risk of CRC in the Chinese population. We
herein report the results of a case-control study that we performed
to investigate the allelic variants on 8q24 and their effect on CRC
risk in a Chinese population. To further investigate the association
of variant rs6983267 with the CRC risk, a systemic review of the
literature published about the locus was undertaken, and a meta-
analysis was conducted.
Materials and Methods
Study populations
Most of the participants in the study have been described
previously [16]. In brief, a total of 478 CRC patients and 838
controls aged between 30 and 80 years old were enrolled between
2001 and 2003 from three hospitals (Xi’nan Hospital, Xinqiao
Hospital and Daping Hospital) in Chongqing, China. The subjects
were genetically unrelated ethnic Han Chinese from Chongqing
and the surrounding regions served by these hospitals, including
parts of Sichuan, Yunnan and Guizhou provinces in southwest
China, which are adjacent to Chongqing. The recruitment
followed the Japan, Korea and China Colorectal Cancer
Collaboration Group guidelines. All patients had been histopath-
ologically diagnosed with primary CRC within the past 6 months,
and had not received any treatment. The medical records of the
patients were thoroughly checked and for those who were suffering
from ileocecal junction tumors or anal canal tumors and those
with any of the following conditions: i. recurrence of CRC; ii.
familial adenomatous polyposis (FAP); iii. hereditary nonpolyposis
colorectal cancer (HNPCC); iv. other tumors; v. severe digestive
tract diseases lasting over 2 years; vi. diabetes, fatty liver, hepatic
cirrhosis, metabolic syndrome or severe cardiovascular diseases
were excluded from the study. One or two controls matched to
each eligible case based on age (65 years), sex and residence were
selected. The controls were recruited from non-CRC patients seen
in the Departments of General Surgery, Orthopedics or Trauma
who were admitted for trauma, bone fractures, appendicitis,
arthritis, or varicose veins. Patients with tumors, severe digestive
tract diseases lasting over 2 years, diabetes, fatty liver, hepatic
cirrhosis, metabolic syndrome or severe cardiovascular diseases
were also excluded from the control group.
A 5-mL peripheral venous blood sample was obtained from
each subject after written informed consent was obtained. Each
participant was personally interviewed by trained interviewers to
complete a Semi-quantitative Food Frequency Questionnaire
(SQFFQ), which collected demographic information and infor-
mation about dietary, and smoking habits (current smoker, former
or never smoker), alcohol use (more or less than 15 g/day,
according to the recommended level of daily alcohol consumption
suggested by the China Health Care Association) and other
lifestyle factors [16]. After quality control procedures were
completed for both SQFFQ and DNA samples, a total of 435
patients and 788 controls of Han ethnicity were finally included in
the study.
Ethics statement
The study was approved by all of the ethics committees of the
participating hospitals (‘‘Ethics Committee of Xi’nan Hosipital’’,
‘‘Ethics Committee of Xinqiao Hosipital’’ and ‘‘Ethics Committee
of Daping Hosipital’’). All of the samples were collected with a
written informed consent provided by the participants, and all
protocols were approved by the human research ethics committees
of the participating hospitals.
Selection of SNPs on 8q24
Genome-wide association studies and gene-based candidate
studies have confirmed that chromosome 8q24 is a susceptibility
region for CRC. It has also been shown that specific loci on 8q24
are associated with specific cancers [14]. Among these loci are two
SNPs, rs6983267 and rs10505477, which were separately found to
be associated with CRC risk [5,17]. These two SNPs are in high
linkage disequilibrium (LD) in the Chinese population (r
2=0.95)
according to the Hapmap database, and they were also found to
be associated with an increased risk of prostate, breast and ovarian
cancers in many population studies [4,18,19]. We chose to further
study the association of rs6983267 with colorectal cancer in the
Chinese population. Another 3 SNPs, rs16901979, rs1447295 and
rs7837688, which were previously found to be associated with
prostate cancer, were also selected to evaluate their association
with colorectal cancer risk in the Chinese population [14,20].
DNA isolation and genotyping
Genomic DNA was extracted from 2.5-mL of whole blood with
a Promega DNA Purification Wizard kit according to the
manufacturer’s instructions. The genotyping methods have been
reported previously [16]. Three SNPs (rs16901979, rs1447295 and
rs7837688) were genotyped using the Applied Biosystems SNPLex
system (Applied Biosystems Incorporated, California, USA)
together with 45 other loci including previously reported loci on
CYP2E1 [16]. Loci were submitted online to ABI Inc for probe
design and synthesis. The OLA (oligonucleotide ligation assay),
purification, and PCR reactions were performed on an Eppendorf
5333 Mastercycler, and allele inspection was performed on an ABI
3130xl Gene Analyzer. The SNP information was collected using
Data Collection Software version 3.0, and data were analyzed by
the GeneMapper Software version 4.0. Another locus (rs6983267)
was genotyped using a TaqManH SNP Genotyping Assay (Applied
Biosystems Incorporated, California, USA) on a 7900HT Fast
Real-Time PCR System (Applied Biosystems Incorporated,
California, USA). A total of 10% of the samples were randomly
selected for duplication for these loci to assess the reproducibility
of the genotyping calls and a more than 99% concordance rate
was found.
Meta-analysis of the rs6983267 locus in subjects with
colorectal neoplasia
In order to explore the association between rs6983267 and the
risk of colorectal neoplasia, a meta-analysis was conducted. We
performed a comprehensive and systematic bibliographic search
updated to February of 2011 based on the MEDLINE and
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in combination with ‘‘colorectal neoplasia’’, ‘‘colorectal cancer’’ or
‘‘colorectal adenoma’’ to search the database to identify the studies
regarding the association between the rs6983267 polymorphism
and the risk of colorectal cancer. References were also checked to
identify any missing studies. The details of the studies were
thoroughly examined in order to exclude potentially overlapping
data. If the same participants were used in different papers, only
the largest and most complete study was included here. The
studies included were those that provided data about rs6983267
and the risk of colorectal cancer or colorectal adenomas and could
be case-control, cohort or cross-sectional studies that were
reported in English. The studies included should also provide
sufficient data about the frequency of the genotypes. Individual
authors were also contacted for further data when the criteria were
not met. The flow chart that tracks the selection process for the
studies and the reasons for exclusion is presented in Figure 1.
For each study, the following information was recorded: first
author, publication year, study design, study location, study
population/ethnicity, total number and sources of cases and
controls, sub-group and disease categories, total number of cases
and controls, and the allele frequency in the study. When there
were sub-group studies described in the paper (such as those
stratified by ethnicity, study stage, etc), they were considered
individually. Pooled allelic effects were estimated both under a
fixed effects model and a random effects model, and the pooled
OR with its 95% CIs was used as the summary measurement.
Statistical analysis
The prevalence of each of the alleles was measured in cases and
controls. The x
2 test (for categorical variables) and Student’s t-test
(for continuous variables) were used to evaluate the differences in
demographic characteristics and selected variables. Hardy-Wein-
berg Equilibrium (HWE) was assessed by the x
2 test (1 degree of
freedom (d.f)). The common homozygote was used as the reference
to calculate the genotype-specific odds ratio (OR) and its 95%
confidence intervals (CI) with or without adjustment for age, sex,
smoking status and alcohol use under the unconditional Logistic
regression statistic model. The statistical powers of the study were
calculated using the Power software under the assuming of two
sided test with alpha level is 0.05 with the log-additive genetic
model [21,22].
For meta-analysis, the pooled OR and its 95% CI were
calculated using the standard inverse variance weighting method
for the fixed effects model and the DerSimonian-Laird method for
the random-effects model. Heterogeneity between studies was
assessed using the Cochrane Q-test in combination with the I
2
statistic. Publication bias was graphically represented by funnel
plotting and was assessed both by Egger’s linear regression [23]
and Begg’s rank correlation tests [24]. Statistical analyses were
Figure 1. The flow chart for the selection of studies and specific reasons for exclusion of studies from the meta-analysis.
doi:10.1371/journal.pone.0018251.g001
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packages (http://www.r-project.org/).
Results
The characteristics of cases and controls are given in Table 1.
There were more patients with a daily average alcohol intake of
more than 15 g/day (P=0.011) in the neoplasia patients, as has
been indicated previously [15]. In addition, the cases were slightly
older than the controls (P=0.017). Other potential confounders
were not significantly different between the cases and controls
(Table 1). The genotyping results of the selected SNPs in the CRC
cases and controls are shown in Table 2. The overall call rate of
each SNP was more than 98%, and no SNP deviated from Hardy-
Weinberg equilibrium (P.0.05, Table 2).
Statistically significant associations were obtained only for the
previously reported SNP rs6983267 (Table 2). Compared to the TT
homozygotes, the GT heterozygotes showed a marginally increased
risk of colorectal cancer (adjusted OR=1.30, 95% CI=0.98–1.71;
P=0.069). However, the GG homozygotes showed a significant,
66% increased risk of colorectal cancer (adjusted OR=1.66, 95%
CI=1.18–2.34; P=0.004). The locus was also found to be
associated with a gene-dose response relationship for an increased
risk for CRC (P-trend=0.003). The statistical power for the
association of SNP rs6983267 and CCR in our study was 0.839 for
the observed OR. We found no statistically significant interactions
between rs6983267 and age, sex, smoking status or alcohol use. No
other locus was found to be significantly associated with the CRC
risk (Table 2). However, the statistical powers for the three loci were
relativelylower(0.290forrs16901979,0.702 for1447295and0.316
for rs7837688 for the observed ORs).
For the meta-analysis regarding the association between colorectal
cancer risk and the variant rs6983267, we identified twenty-three
reports regarding the association between rs6983267 and colorectal
neoplasia. After detailed evaluation, sixteen studies including a total of
36,761 cases and 38,901 controls were used for the meta-analysis
(Table 3) [5,11,12,13,19,25,26,27,28,29,30,31,32,33,34]. Four studies
lacked sufficient data about the genotype frequency [4,14,35,36] and
three studies contained overlapping participants with the included
reports [37,38,39], and were therefore excluded from the analysis
(Figure 1). For rs6983267, the summary odds ratio (SOR) was 1.20
(95%=1.16–1.25) under the fixed effects model and the random
effects model for the GT heterozygotes compared to the TT
homozygotes (Figure 2). There was no significant heterogeneity
between the studies (Q=21.77, df=29, P=0.829; I
2=0%), and no
evidence of a significant publication bias was found (Begg’s test,
P=0.630; Egger’s test, P=0.465). For the GG homozygotes, we noted
that there was a significant increase in colorectal neoplasia, with the
SOR of 1.40 (95% CI=1.33–1.46) under the fixed effects model and
1.39 (95% CI =1.32–1.48) under the random effects model compared
to the TT carriers (Figure 3). However, significant heterogeneity was
found among these studies (Q=43.39, df=29, P=0.042; I
2=33.2%).
However, there still no significant publication bias (Begg’s test,
P=0.762; Egger’s test, P=0.783). Sensitivity analyses were also
performed by removing the individual studies sequentially, and we
found that none individual studies dramatically affected the overall
polled ORs.
Todeterminewhethertheassociationbetween variantrs6983267
and colorectal neoplasia could differ for colorectal adenomas and
colorectal cancer, we examined the association between the variant
and colorectal cancer and the variant and colorectal adenomas.
Table 1. The characteristics of the participants from a
Chinese population.
Variance Controls (N=788) Cases (N=435) P-value
Age (years)
a 51.73611.29 53.49612.88 0.017
Sex 0.972
female 351 (44.5%) 195 (44.8%)
male 437 (55.5%) 240 (55.2%)
Smoking status 0.547
former and never 488 (61.9%) 261 (60.0%)
current 300 (38.1%) 174 (40.0%)
Alcohol use (.15 g/day) 0.011
yes 152 (19.3%) 112 (25.7%)
no 636 (80.7%) 323 (74.3%)
aAge was presented as the mean 6 SD (years).
doi:10.1371/journal.pone.0018251.t001
Table 2. An association study of 8q24 loci and colorectal cancer risk.
SNP Genotype
Controls
(N %)
Cases
(N %)
Crude OR
(95% CI)
Adjusted OR
a
(95% CI) P value
a P-trend
a Call rate
HWE-test
P-value
rs16901979 CC 403 (51.5) 219 (50.7) 1 1 99.3% 0.66
AC 321 (41.0) 171 (39.6) 0.98 (0.76–1.26) 0.95 (0.74–1.22) 0.706
AA 58 (7.4) 42 (9.7) 1.33 (0.87–2.05) 1.30 (0.84–2.00) 0.243 0.550
rs6983267 TT 256 (32.6) 111 (25.8) 1 1 99.4% 0.61
GT 392 (49.9) 219 (50.9) 1.29 (0.98–1.70) 1.30 (0.98–1.71) 0.069
GG 138 (17.6) 100 (23.3) 1.67 (1.19–2.35) 1.66 (1.18–2.34) 0.004 0.003
rs1447295 CC 567 (72.5) 294 (67.9) 1 1 99.3% 0.39
AC 202 (25.8) 127 (29.3) 1.21 (0.93–1.58) 1.22 (0.94–1.59) 0.140
AA 13 (1.7) 12 (2.8) 1.78 (0.80–3.95) 1.73 (0.78–3.87) 0.180 0.062
rs7837688 GG 587 (75.8) 308 (71.0) 1 1 98.8% 1.00
TG 175 (22.6) 117 (27.0) 1.27 (0.97–1.67) 1.26 (0.95–1.65) 0.103
TT 12 (1.6) 9 (2.1) 1.43 (0.60–3.43) 1.38 (0.57–3.32) 0.479 0.089
aAdjusted for age, sex, alcohol use and smoking status.
doi:10.1371/journal.pone.0018251.t002
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association between the variant and colorectal adenomas, with a
total of 4,197 cases and 5,109 controls [5,12]. All of the reports
studied the association between rs6983267 and colorectal cancer,
with a pool of 32,564 total cases and 34,752 controls. From the
meta-analysis, we found that the SORs for GT heterozygotes and
GG homozygotes compared to the TT homozygotes were similar in
magnitude to those found for colorectal adenomas and total
colorectal cancer(Table4).Inthe subgroupanalysisbyethnicity,we
found that the variant rs6983267 was associated with an increased
risk of colorectal neoplasia both in the Asian populations (9,207
cases and 8,368 controls) and the Caucasians (23,818 cases and
25,021 controls), although there was a slight different of the pooled
ORbetweentheAsianpopulationsandfortheCaucasians(Table4).
Discussion
Variants on 8q24 (position 128.14 Mb to 128.62 Mb) were
found to be associated with various types of cancer. It was reported
by Ghoussaini et al that there are five different haplotype blocks
within this region. The rs6983267 locus and its highly correlated
locus, rs10505477 (r
2=0.95 in CHB population for Hapmap
database), which are located between a 128.47 and 128.54 Mb
region, have been found to be associated with prostate, colorectal
and ovarian cancers [14]. Loci outside this region were also found
to be associated with prostate or breast cancers, but not colorectal
cancer [14]. Our study also found a significant association between
rs6983267 and colorectal cancer in the Chinese population.
However, no significant association for the other three loci, which
are located outside the 128.47 and 128.54 Mb region, was
identified in the Chinese population. As indicated in our previous
study and in other studies, alcohol use is a risk factor for colorectal
cancer. In the stratification analysis, we found a trend toward a
stronger association in the participants without a drinking habit
(,15 g/d), however, we found no statistically significant interac-
tions between the variant rs6983267 and alcohol use. We also did
not find any significant interactions between rs6983267 CRC risk
and other potential confounders. These findings were consistent
Table 3. Studies included in the meta-analysis of the association of rs6983267 with colorectal neoplasia.
Study
(First author, year) Country and ethnicity Study design
Sub-group study and
disease category Cases Controls Ref
Tomlinson, 2007 UK, Caucasian Population based case-control CORGI, cancer 620 960 [5]
UK, Caucasian Population based case-control CORGI, adenomas 407
UK, Caucasian Nested case-control NSCCG, cancer 4361 3752
UK, Caucasian Nested case-control NSCCG, cancer 1901 1079
UK, Caucasian Nested case-control VICTOR, cancer 1072 415
UK, Caucasian Nested case-control UKCAP, adenomas 607 765
UK, Caucasian Population based case-control FlexiScope, adenomas 463 411
Poynter, 2007 USA and Canada, Mixed ethnic Population based case-control Cancer 1339 2191 [11]
USA and Canada, Mixed ethnic Hospital based case-control Cancer 288 502
Berndt, 2008 USA, Caucasian Nested case-control Adenomas 2569 2779 [12]
USA, Mixed ethnic Nested case-control Adenomas 151 194
USA, Caucasian Nested case-control Cancer 538 1644
USA, Mixed ethnic Nested case-control Cancer 71 165
Tuupanen, 2008 Finland, Caucasian Population based case-control Cancer 996 1012 [13]
Wokolorczyk, 2008 Poland, Caucasian Hospital based case-control Cancer 779 1910 [19]
Li, 2008 USA, Caucasian Population based case-control Cancer 527 679 [25]
USA, Mixed ethnic Population based case-control Cancer 34 42
Curtin, 2009 UK and USA, Caucasian Population based case-control Cancer 1069 1040 [26]
Matsuo, 2009 Japan, Japanese Hospital based case-control Cancer 481 962 [27]
Schafmayer, 2009 Germany, Caucasian Population based case-control Cancer 2712 2713 [28]
Middeldorp, 2009 Netherlands, Caucasian Population based case-control Cancer 995 1340 [29]
Kupfer, 2009 USA, African American Hospital based case-control Cancer 1795 2378 [30]
USA, Caucasian Hospital based case-control Cancer 399 367
Holst, 2010 Sweden, Caucasian Population based case-control Cancer 1786 1749 [31]
Xiong, 2010 China, Chinese Han Hospital based case-control Cancer 2124 2124 [32]
Hutter, 2010 USA, Caucasian Population based case-control Cancer 1461 1813 [33]
USA, Caucasian Nested case-control Cancer 614 633
Cui, 2011 Japan, Japanese Population based case-control Screening stage, cancer 1583 1898 [34]
Japan, Japanese Population based case-control Replication 1,cancer 3099 1777
Japan, Japanese Population based case-control Replication 2, cancer 1485 819
Li, 2011 China, Chinese Han Hospital based case-control Cancer 435 788
doi:10.1371/journal.pone.0018251.t003
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rs6983267 and colorectal cancer may not modified by the age at
diagnosis [11,12,25,27], sex [12,25,27], family history of CRC
[11,12,25,27], smoking status [27], or alcohol use [27]. However,
the current study is a hospital based case-control study and the
number of participants was relatively small, which may have led to
spurious results. Whether the association between rs6983267 and
colorectal neoplasia was affected by the confounders needs further
investigation.
In the meta-analysis of rs6983267 and colorectal neoplasia,
sixteen eligible papers that examined the risk of colorectal
carcinoma, including two that also reported the association between
the locus and colorectal adenomas risk were examined. We found
that the GT heterozygotes had a 20% (95% CI=1.16–1.25;
random effects model) and the GG homozygotes showed a 39%
(95% CI=1.32–1.48; random effects model) increased risk of
colorectal neoplasia. The SORs determined for colorectal neoplasia
were similar in magnitude to those observed for colorectal cancer
and colorectal adenomas (Table 4). These findings indicated that
rs6983267 may play a similar role in the etiology of both colorectal
cancer and colorectal adenomas. Although the frequency for the
risk allele G was different in different populations (0.487 in CEU,
0.394 in CHB and 0.301 in JPT according to Hapmap database),
we also found that the strength of the association between
rs6983267 and colorectal neoplasia were similar between the
Caucasian and Asian populations (Table 4), which was consistent
with a previous meta-analysis study conducted by Hutter et al
concerning the association between this locus and CRC risk [33].
Although the variant rs6983267 had been found to be
associated with an increased susceptibility to colorectal neoplasia,
whether the rs6983267 SNP is the causal locus is still uncertain.
Several recently published studies have shown that rs6983267 is
located within a transcriptional enhancer region and affects a
binding site for TCF4 (also called TCF7L2), a transcription factor
which is activated in most CRCs. TCF4 interacts with b-catenin to
activate the transcription of Wnt target genes, which are part of a
Figure 2. A forest plot of the association of colorectal neoplasia with rs6983267 heterozygosity (G/T vs. T/T).
doi:10.1371/journal.pone.0018251.g002
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that the rs6983267 G allele has an approximately 1.5-fold stronger
enhancer activity and increased affinity for TCF4 compared to the
T allele. And Pomerantz et al. demonstrated that a DNA fragment
region containing the variant shows a long-range physical
interaction with the MYC promoter located ,330 kb downstream
using a chromatin conformation capture (3C) technique [40].
These findings indicate the biological mechanism(s) that poten-
tially underlie the role of this non-protein-coding risk variant, and
indicated that rs6983267 may be a causal variant for the
susceptibility to CRC.
There are several potential limitations to the current study. First,
for a hospital-based case-control study, subjects were recruited
based on their outcome (with CRC or without CRC) rather than
their exposure. The potential CRC risks for the controls are
immeasurable, and may have caused a cause bias in studying the
etiology of the disease. It could also have led to spurious results in
thegene/environmentalinteraction studies. Second, the samplesize
was relatively small. We cannot exclude the possibility there is an
association between rs16901979, rs1447295 and rs7837688 and
colorectal cancer in the Chinese population due to the inadequate
statistical power of our study (0.290 for rs16901979, 0.702 for
1447295 and 0.316 for rs7837688, respectively), although many
other studies have also reported no significant association for these
loci with CRC in other populations [12,14,26,28]. Accordingly, the
null interaction between the confounders (alcohol use, smoking
status, sex, age) and rs6983267 may also be due to the low power of
small sample size. Third, there are at least five different cancer
susceptibility regions on the 8q24 ‘‘desert’’ as reported by
Ghoussaini et al [14]. Only the loci in the third region such as
rs6983267 and rs10505477, were found to be significantly
associated with CRC, and evidence from the in vitro experiment
indicated that rs6983267 may be the causal locus, although we
cannot exclude the possibility that other functional variants which
Figure 3. A forest plot of the association of colorectal neoplasia with rs6983267 homozygosity (G/G vs. T/T).
doi:10.1371/journal.pone.0018251.g003
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CRC. This study evaluated the representative loci from different
regions on 8q24 and their association with CRC risk in an Asian
(Han Chinese), which has been not well studied for these variants so
far. It is valuable to conduct a fine-mapping study for the third
region to identify other potential causal variants that are associated
with CRC risk in a larger Chinese population.
In summary, we observed a statistically significant association
between SNP rs6983267 on 8q24 and the risk of colorectal cancer
in a Chinese population. Moreover, a meta-analysis of previous
studies conducted in different populations confirmed the associ-
ation between this locus and colorectal neoplasia risk in different
populations and ethnic groups. These results provide a more
complete picture of the role of this polymorphism in the risk of
colorectal neoplasia, and may give genetic insight into possible
strategies for prevention of colorectal neoplasia.
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